[HTML][HTML] Exploitation of glycosylation in enveloped virus pathobiology
Y Watanabe, TA Bowden, IA Wilson… - Biochimica et Biophysica …, 2019 - Elsevier
Glycosylation is a ubiquitous post-translational modification responsible for a multitude of
crucial biological roles. As obligate parasites, viruses exploit host-cell machinery to …
crucial biological roles. As obligate parasites, viruses exploit host-cell machinery to …
Passive immunotherapy of viral infections:'super-antibodies' enter the fray
LM Walker, DR Burton - Nature Reviews Immunology, 2018 - nature.com
Antibodies have been used for more than 100 years in the therapy of infectious diseases,
but a new generation of highly potent and/or broadly cross-reactive human monoclonal …
but a new generation of highly potent and/or broadly cross-reactive human monoclonal …
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)
coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic …
coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic …
Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G
Summary The HIV-1-envelope (Env) trimer is covered by a glycan shield of∼ 90 N-linked
oligosaccharides, which comprises roughly half its mass and is a key component of HIV …
oligosaccharides, which comprises roughly half its mass and is a key component of HIV …
[HTML][HTML] Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth
Detailed studies of the broadly neutralizing antibodies (bNAbs) that underlie the best
available examples of the humoral immune response to HIV are providing important …
available examples of the humoral immune response to HIV are providing important …
Global aspects of viral glycosylation
I Bagdonaite, HH Wandall - Glycobiology, 2018 - academic.oup.com
Enveloped viruses encompass some of the most common human pathogens causing
infections of different severity, ranging from no or very few symptoms to lethal disease as …
infections of different severity, ranging from no or very few symptoms to lethal disease as …
Advances in development and application of influenza vaccines
J Chen, J Wang, J Zhang, H Ly - Frontiers in immunology, 2021 - frontiersin.org
Influenza A virus is one of the most important zoonotic pathogens that can cause severe
symptoms and has the potential to cause high number of deaths and great economic loss …
symptoms and has the potential to cause high number of deaths and great economic loss …
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
The threat of a major coronavirus pandemic urges the development of strategies to combat
these pathogens. Human coronavirus NL63 (HCoV-NL63) is an α-coronavirus that can …
these pathogens. Human coronavirus NL63 (HCoV-NL63) is an α-coronavirus that can …
[HTML][HTML] New viral vectors for infectious diseases and cancer
E Sasso, AM D'Alise, N Zambrano, E Scarselli… - Seminars in …, 2020 - Elsevier
Since the discovery in 1796 by Edward Jenner of vaccinia virus as a way to prevent and
finally eradicate smallpox, the concept of using a virus to fight another virus has evolved into …
finally eradicate smallpox, the concept of using a virus to fight another virus has evolved into …
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
PJM Brouwer, A Antanasijevic, AJ Ronk… - Cell Host & Microbe, 2022 - cell.com
The Lassa virus is endemic in parts of West Africa, and it causes hemorrhagic fever with high
mortality. The development of a recombinant protein vaccine has been hampered by the …
mortality. The development of a recombinant protein vaccine has been hampered by the …